Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesContribution of Genome-Wide Significant Single Nucleotide Polymorphisms and Antiretroviral Therapy to Dyslipidemia in HIV-Infected Individuals - A Longitudinal Study
Circulation: Cardiovascular Genetics, 09/23/09
Rotger M et al. – In the HIV–infected population treated with ART, the weight of the contribution of common SNPs and ART to dyslipidemia was similar. When selecting an ART regimen, genetic information should be considered in addition to the dyslipidemic effects of ART agents.
Related Articles
Impact of fixed-dose and multi-pill combination dyslipidemia therapies on medication adherence and the economic burden of sub-optimal adherence
Current Medical Research and Opinion, 10/05/09
Relevance Score: 85%
Corneal Arcus and Cardiovascular Risk Factors in Middle-Aged Subjects in Taiwan
The American Journal of the Medical Sciences, 10/14/09
Relevance Score: 84%
Efficacy and Safety of Ezetimibe Plus Orlistat or Rimonabant in Statin-Intolerant Nondiabetic Overweight/Obese Patients With Dyslipidemia
Journal of Cardiovascular Pharmacology and Therapeutics, 11/12/09
Relevance Score: 83%
Effects of ezetimibe add-on therapy for high-risk patients with dyslipidemia
Lipids in Health and Disease, 10/13/09
Relevance Score: 83%
Critical appraisal of the role of pitavastatin in treating dyslipidemias and achieving lipid goals
Vascular Health and Risk Management, 11/03/09
Relevance Score: 82%
Today in Atherosclerosis/Lipids...keeping you current
Receive free subspecialty "5-minute updates" via email
Hyperlipidemia in Older Adults
Clinics in Geriatric Medicine, 12/01/09
Life Course Socioeconomic Conditions and Metabolic Syndrome in Adults: The Atherosclerosis Risk in Communities (ARIC) Study
Annals of Epidemiology , 12/01/09
Low-Density Lipoprotein Cholesterol Reduction and Goal Achievement With Ezetimibe/Simvastatin Versus Atorvastatin or Rosuvastatin in Patients With Diabetes, Metabolic Syndrome, or Neither Disease, Stratified By National Cholesterol Education Program Risk Category
Metabolic Syndrome and Related Disorders, 11/30/09
Sponsor
Article Search
Sponsor